Skip to Main Content
Accessibility Overview
webinar register page
Topic
Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation
Description
In this webinar, you can learn the steps involved in developing enhanced Self-Emulsifying Drug Delivery Systems (SEDDS) formulations based on their surfactant emulsion properties, including droplet size and hydrophilicity.
BASF generated in vitro information via Pion technology, and as a result, were able to report enhanced In vitro – in vivo correlation (IVIVC) performance for SEDDS formulations.
Time
Nov 8, 2022 11:00 AM in
Eastern Time (US and Canada)
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host:
.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Nov 8, 2022 11:00 AM Eastern Time (US and Canada) Topic: Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_ul2UpkPLQsOM0b8C_AumjA After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Nitin K Swarnakar (NA Applications Manager @BASF Pharma Solutions) Dr. Swarnakar has 15 years of combined academic and industrial experience, 11 Indian and 4 US Patents (application/granted), plus more than 30 publications .He has a Bachelor and Masters degrees in Pharma as well as a Doctorate of Philosophy (Pharmaceutics). His key formulation specialties are solubilization of small molecules and peptides, in vitro in vivo correlation, lipid based formulations and polymer based formulations. Karl Box (Chief Scientific Officer - Europe @Pion-Inc.) Karl Box is Chief Scientific Officer (Europe) at Pion Inc. and is involved in scientific and chemistry-related functions within the company, as well as supporting commercial activities and business development. His expertise is in the field of physicochemical measurements where he has forged a successful career in the development of new instrumentation and assays for supporting drug discovery and development.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-9:00) Alaska
(GMT-9:00) Juneau
(GMT-8:00) Vancouver
(GMT-8:00) Pacific Time (US and Canada)
(GMT-8:00) Tijuana
(GMT-7:00) Edmonton
(GMT-7:00) Mountain Time (US and Canada)
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Yukon
(GMT-6:00) Winnipeg
(GMT-6:00) Saskatchewan
(GMT-6:00) Central Time (US and Canada)
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-6:00) Monterrey
(GMT-5:00) Montreal
(GMT-5:00) Eastern Time (US and Canada)
(GMT-5:00) Indiana (East)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Acre
(GMT-4:00) Halifax
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Atlantic Time (Canada)
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:30) Newfoundland and Labrador
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Casablanca
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Jerusalem
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kyiv
(GMT+2:00) Chisinau
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Damascus
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+11:00) Lord Howe IsIand
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...